Key facts
- This page summarizes Mark Christopher Capone's Form 3 filing for DermTech, Inc..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 20 Jul 2022, 20:08.
Mark Christopher Capone - 18 Jul 2022 Form 3 Insider Report for DermTech, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 18 Jul 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 20 Jul 2022, 20:08:20 UTC
- Next SEC filing
- 05 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason S. Miller, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark Christopher Capone filed Form 3 for DermTech, Inc. on 20 Jul 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
Exhibit List Exhibit 24 - Power of Attorney of Mark Capone No securities are beneficially owned.